Clinical Trials Directory

Trials / Completed

CompletedNCT04880252

Neuropsychological Indicators of SCD Progression

In Individuals With Subjective Cognitive Decline, Age, Memory and Action Speed Scores at Baseline Predict Progression to Cognitive Impairment

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Some patients with subjective cognitive decline (SCD) progress to neurocognitive disorders (NCD), whereas others remain stable; however, the neuropsychological determinants of this progression have not been identified. The investigators objective was to examine baseline neuropsychological indicators that could discriminate between people in whom the SCD progressed to a mild or major NCD and people in whom the SCD remained stable. The investigators retrospectively included patients consulting for SCD at a university medical center's memory center (Amiens, France) and who had undergone three or more neuropsychological assessments at least 6 months apart. The relationship between domain-specific scores and the global cognitive score (GCS, as a function of final status (stable SCD vs. progression toward a mild or major NCD)) was examined using a generalized linear mixed model.

Conditions

Timeline

Start date
2019-05-01
Primary completion
2020-05-01
Completion
2020-05-01
First posted
2021-05-10
Last updated
2021-05-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04880252. Inclusion in this directory is not an endorsement.